1382 (Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil 10 mg / 25 mg / 40 mg)
Pill with imprint 1382 is Red, Elliptical/Oval and has been identified as Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil 10 mg / 25 mg / 40 mg. It is supplied by Torrent Pharmaceuticals Limited.
Amlodipine/hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Amlodipine/hydrochlorothiazide/olmesartan 10 mg / 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1382

Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil
- Imprint
- 1382
- Strength
- 10 mg / 25 mg / 40 mg
- Color
- Red
- Size
- 11.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antihypertensive combinations
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Torrent Pharmaceuticals Limited
- National Drug Code (NDC)
- 13668-0382
- Inactive Ingredients
-
croscarmellose sodium,
silicon dioxide,
magnesium stearate,
magnesium silicate,
lactose monohydrate,
corn starch,
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC),
titanium dioxide,
ferric oxide yellow,
ferric oxide red,
polyethylene glycol 400
Note: Inactive ingredients may vary.
Related images for "1382"
More about amlodipine / hydrochlorothiazide / olmesartan
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (20)
- Drug images
- Pricing & coupons
- En español
- Drug class: miscellaneous antihypertensive combinations
Patient resources
- Drug Information
- Olmesartan, amlodipine, and hydrochlorothiazide (Advanced Reading)
- Olmesartan, Amlodipine, and Hydrochlorothiazide
- Other brands
- Tribenzor
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.